Cite
HARVARD Citation
Feldmann, M. et al. (n.d.). The rationale for the current boom in anti-TNFα treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards?. Annals of the rheumatic diseases. pp. I27-I31. [Online].